Recently, Lotus Health Group Company(600186) disclosed the annual report of 2021 and the first quarterly report of 2022. In 2021, the company achieved a sales revenue of 1.815 billion yuan, a year-on-year increase of 9.69%; The non net profit attributable to the shareholders of the listed company is RMB 45.25 million. In the first quarter of 2022, the sales revenue was 417 million yuan, a year-on-year increase of 0.72%; The net profit attributable to shareholders of listed companies was 14.653 million yuan, a year-on-year increase of 32.8%.
In 2021, Lotus Health Group Company(600186) ‘s corporate governance continued to improve and its business performance continued to improve, overcoming various internal and external difficulties and challenges, including the epidemic. At the same time, Lotus Health Group Company(600186) internal management was continuously optimized and various businesses were vigorously expanded. During the reporting period, the expenses decreased significantly compared with the same period last year. During the reporting period, the sales expenses decreased by 16.79%, the management expenses decreased by 14.64% and the financial expenses decreased by 47.52% year-on-year. The fundamentals of the company have been fundamentally improved.
In 2021, Lotus Health Group Company(600186) non-public offering of shares was successfully completed, with a total amount of 994 million yuan raised. The successful implementation of the company’s refinancing has laid a solid foundation for increasing the company’s credit, reducing operational risks and costs, strengthening the quality of cash flow, improving profitability and core competitiveness, and realizing leapfrog high-quality development.
It is worth noting that Lotus Health Group Company(600186) currently has no interest bearing liabilities, and the net cash flow from operating activities has changed to a negative state for many years. Superimposed with a series of financial indicators such as the sharp decline of the company’s period expenses, it shows that the company’s financial situation is stable and its capital strength is continuously enhanced.
During the reporting period, Lotus Health Group Company(600186) further optimized the sales channels, and the online sales increased by 231% year-on-year, while the online sales model is more in line with the modern and younger consumption habits, which helps to promote the steady and healthy development of the company. In order to catch the general trend of consumption upgrading, Lotus Health Group Company(600186) cooperates deeply with scientific research institutions of colleges and universities and enterprises in the industry to develop “recipe compound seasoning” matching the “lazy” and “house” economy. At present, new products in line with the new consumption flavor such as “braised sauce”, “catering cooking wine” and “xianweibao” are scheduled to be listed. In 2021, the operating revenue of liquid condiments such as cooking wine increased by 19.34% year-on-year.
Looking forward to the future, facing the trend of consumption upgrading and the change of market competition pattern, Lotus Health Group Company(600186) said that the company will continue to adhere to the product policy of paying equal attention to traditional condiments and new products, expand product categories, increase new product research and development and market promotion, promote the transformation and upgrading of the company’s strategic products, and promote the steady, sustainable and healthy development of the company Lotus Health Group Company(600186) will grasp the market development opportunities, give play to the advantages of brands and channels, and accelerate the release of development potential.
